|
|
Leukemia - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
1. Studying Immune System Reconstitution Following Unrelated Donor Transplantation and Graft-Versus-Host-Disease Prevention (Posted: 01/13/2009) - Patients with high-risk, advanced hematologic malignancies will undergo induction chemotherapy, reduced-intensity immune-depleting chemotherapy, and allogeneic stem cell transplantation from a matched, unrelated donor, followed by graft-versus-host disease prevention.
2. Preventing Respiratory Infections in Patients with CLL (Posted: 10/21/2008) - This Featured Clinical Trial is a randomized, double-blind, placebo-controlled study to test the ability of CVT-E002 (COLD-fx) to reduce acute respiratory infections and the need for antibiotic treatment during the peak respiratory illness season (January through March) in people with chronic lymphocytic leukemia.
3. Inhibiting Tumor Angiogenesis in Children (Posted: 01/22/2008) - In this trial, researchers are testing an angiogenesis inhibitor called cediranib in pediatric patients who have solid tumors (except brain tumors) or acute myeloid leukemia (AML), a type of blood cancer.
4. Targeted Therapy for Lymphoid Cancers (Posted: 05/29/2007) - Patients with T-cell or B-cell lymphoid cancers that have recurred or progressed despite prior chemotherapy will receive the drug ABT-263 orally for up to a year in this phase I/II clinical trial.
5. Monoclonal Antibody Therapy for Treatment-Resistant Blood Cancers (Posted: 03/29/2005, Updated: 05/16/2007) - This phase I dose-escalation study is investigating safety and tolerability of siplizumab, and will determine the maximum dose that can be given to patients with CD2-positive lymphoproliferative disease.
1 2 3 4 Next > |
|
|